Alto Neuroscience (ANRO) Return on Capital Employed (2024 - 2026)

Alto Neuroscience has disclosed Return on Capital Employed across 3 years of filings, most recently posting 35.81% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 35.81%, up 593.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 35.81% (up 593.0% YoY), and the FY2025 annual result was 39.09%, up 1712.0% from the prior year.
• Return on Capital Employed came in at 35.81% for Q1 2026 at Alto Neuroscience, up from 42.95% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 27.97% in Q2 2024 to a low of 46.24% in Q3 2025.
• The 3-year median for Return on Capital Employed is 39.3% (2024), against an average of 38.45%.
• Across the five-year window, Return on Capital Employed tumbled 1683 bps in 2025 and soared 593 bps in 2026, its largest moves.
• Alto Neuroscience's Return on Capital Employed stood at 39.3% in 2024, then retreated by 9 bps to 42.95% in 2025, then gained by 17 bps to 35.81% in 2026.
• The last three Return on Capital Employed figures came in at 35.81% (Q1 2026), 42.95% (Q4 2025), and 46.24% (Q3 2025), per Business Quant data.